Resalutem Pharmaceutical Private Limited
About Resalutem Pharmaceutical Private Limited
Data last updated:
Resalutem Pharmaceutical Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2016PTC085863. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Raheem Hakeemsaiyed Saiyed and Hakim Lalbhai Saiyed.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 350 Maruti Nagar Limbayat, Surat, Gujarat, India – 394210.
As per the financials filed for FY 2020, the company reported a revenue of ₹11.22 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹31,239 (net margin 2.8%) and EBITDA of ₹37,986 (EBITDA margin 3.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Resalutem Pharmaceutical Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address350 Maruti Nagar Limbayat, Surat, Gujarat, India – 394210
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Resalutem Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Resalutem Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Resalutem Pharmaceutical Private Limited, buy the company report.
Financials of Resalutem Pharmaceutical Private Limited
FY 2020 filings availableResalutem Pharmaceutical Private Limited reported revenue of ₹11.22 Lakh (up 184% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 184% in the latest year. EBITDA rose 198% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37,986 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,239 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Resalutem Pharmaceutical Private Limited, buy the company report.
Board of directors of Resalutem Pharmaceutical Private Limited
Resalutem Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raheem Hakeemsaiyed Saiyed | Director | 28 Jan 2016 | 10 Years 9 Months | Current |
| Hakim Lalbhai Saiyed | Director | 28 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Resalutem Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meshram Chemtech Private Limited | ₹11.28 Lakh (FY 2024) | 114.0% | Nagpur, Maharashtra, India | |||
| Abvita Pharmaceuticals Private Limited | ₹11.28 Lakh (FY 2023) | -73.0% | Hyderabad, Telangana, India | |||
| Mohini Hygiene Care Products Private Limited | ₹11.25 Lakh (FY 2025) | -92.0% | Pithampur, Madhya Pradesh, India | |||
| Brit Allvin Pharmaceautical Private Limited | ₹11.25 Lakh (FY 2024) | 18.0% | Karnal, Haryana, India | |||
| Tejika Labs Private Limited | ₹11.25 Lakh (FY 2023) | 46.0% | Ankleshwar, Gujarat, India | |||
| Resalutem Pharmaceutical Private Limitedthis company | ₹11.22 Lakh (FY 2020) | ₹31,239 | 2.8% | 184.0% | Surat, Gujarat, India | |
| Alible Pharmaceutical Private Limited | ₹11.22 Lakh (FY 2025) | 10.0% | Thane, Maharashtra, India | |||
| Mahija Biofuel Industries Private Limited | ₹11.21 Lakh (FY 2023) | Ahmedabad, Gujarat, India | ||||
| Ignis Control Systems Private Limited | ₹11.2 Lakh (FY 2022) | 254.0% | Bangalore, Karnataka, India | |||
| Swabhi Pharma Private Limited | ₹11.2 Lakh (FY 2022) | 64.0% | Delhi, India | |||
| Ashoka Biotech Private Limited | ₹11.18 Lakh (FY 2023) | 107536250.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Resalutem Pharmaceutical Private Limited, buy the company report.
Auditor
Resalutem Pharmaceutical Private Limited is audited by MORAKHIA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MORAKHIA & ASSOCIATES | FY 2017 | 140924W |
Shareholding
The shareholding of Resalutem Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Resalutem Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Resalutem Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Resalutem Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Resalutem Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Resalutem Pharmaceutical Private Limited, buy the company report.
Recent activity
Resalutem Pharmaceutical Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Hakim Lalbhai Saiyed was appointed as Director on 28 Jan 2016.
Frequently asked questions
Resalutem Pharmaceutical is an active private limited company based in Surat, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 January 2016 (10+ years old) and is registered under CIN U51909GJ2016PTC085863.
Resalutem Pharmaceutical has 2 current directors:
- Raheem Hakeemsaiyed Saiyed - Director
- Hakim Lalbhai Saiyed - Director
The latest financial statements of Resalutem Pharmaceutical on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2016 are in the company report.
No. Resalutem Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Resalutem Pharmaceutical is U51909GJ2016PTC085863. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Resalutem Pharmaceutical was incorporated on 28 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Resalutem Pharmaceutical by revenue are Meshram Chemtech Private Limited, Abvita Pharmaceuticals Private Limited, Mohini Hygiene Care Products Private Limited, Brit Allvin Pharmaceautical Private Limited, Tejika Labs Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hakim Lalbhai Saiyed was appointed as Director on 28 Jan 2016. Raheem Hakeemsaiyed Saiyed was appointed as Director on 28 Jan 2016.
The registered office of Resalutem Pharmaceutical is at 350 Maruti Nagar Limbayat, Surat, Gujarat, India – 394210.
Resalutem Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Resalutem Pharmaceutical is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
